Smoking cessation alters intestinal microbiota: Insights from quantitative investigations on human fecal samples using FISH

Inflammatory Bowel Diseases

Volumn 20, Issue 9, 2014, Pages 1496-1501

  Biedermann, Luc ^a   Brülisauer, Karin ^b   Zeitz, Jonas ^a   Frei, Pascal ^a,c   Scharl, Michael ^a,d   Vavricka, Stephan R ^a,d,e   Fried, Michael ^a   Loessner, Martin J ^b   Rogler, Gerhard ^a,d   Schuppler, Markus ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c See Spital Horgen   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Fluorescence in situ hybridization; Inflammatory bowel disease; Intestinal microbiota; Metabolic syndrome; Smoking cessation

Indexed keywords

ALPHAPROTEOBACTERIA; ARTICLE; BACTEROIDES; BETAPROTEOBACTERIA; BIFIDOBACTERIUM; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; EUBACTERIUM; EUBACTERIUM RECTALE; FECES ANALYSIS; FECES MICROFLORA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTESTINE FLORA; NONHUMAN; NORMAL HUMAN; OBSERVATIONAL STUDY; OLIGONUCLEOTIDE PROBE; PREVOTELLA; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; SMOKING; SMOKING CESSATION; BACTERIAL COUNT; DIAGNOSTIC USE; FECES; GENETICS; INTESTINE; MICROBIOLOGY; MICROFLORA; PROCEDURES;

BACTERIAL DNA; OLIGONUCLEOTIDE PROBE;

COLONY COUNT, MICROBIAL; DNA, BACTERIAL; FECES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINES; MICROBIOTA; OLIGONUCLEOTIDE PROBES; SMOKING CESSATION;

EID: 84925863353     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000129     Document Type: Article

References (47)

1. Pace NR. A molecular view of microbial diversity and the biosphere. Science. 1997;276:734-740.
2. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444: 1027-1031.
3. Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070-11075.
4. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101:15718-15723.
5. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328:228-231.
6. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103.
7. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60.
8. Mouzaki M, Comelli EM, Arendt BM, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58: 120-127.
9. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538-541.
10. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(suppl 1): 4592-4598.
11. Codling C, O'Mahony L, Shanahan F, et al. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci. 2010;55:392-397.
12. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24-33.
13. Seksik P, Nion-Larmurier I, Sokol H, et al. Effects of light smoking consumption on the clinical course of Crohn's disease. Inflamm Bowel Dis. 2009;15:734-741.
14. Frank DN, St. Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780-13785. Available at: http://www.pnas.org/content/104/34/13780.abstract.
15. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-214.
16. Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science. 2013;341:1237439.
17. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4554-4561.
18. Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.
19. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces Profound changes in the composition of the intestinal microbiota in humans. PLoS One. 2013;8:e59260. Available at: http://dx.doi.org/10.1371% 2Fjournal.pone.0059260.
20. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996;110:424-431.
21. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471.
22. Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol. 2001;96:2113-2116.
23. O'Hara P, Connett JE, Lee WW, et al. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol. 1998; 148:821-830.
24. Stamler J, Rains-Clearman D, Lenz-Litzow K, et al. Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997;65(1 suppl):374S-402S.
25. Rodin J. Weight change following smoking cessation: the role of food intake and exercise. Addict Behav. 1987;12:303-317.
26. Von Wintzingerode F, Göbel UB, Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev. 1997;21:213-229. Available at: http://dx.doi.org/10.1111/j.1574-6976.1997.tb00351.x.
27. Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Microbiol. 2008;6:339-348.
28. Franks AH, Harmsen HJ, Raangs GC, et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 1998;64:3336-3345.
29. Harmsen HJM, Raangs GC, He T, et al. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol. 2002;68:2982-2990.
30. Amann RI, Krumholz L, Stahl DA. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol. 1990;172:762-770.
31. Wallner G, Amann R, Beisker W. Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry. 1993;14:136-143.
32. Manz W, Amann R, Ludwig W, et al. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. Syst Appl Microbiol. 1992;15:593-600. Available at: http://www.sciencedirect.com/science/article/pii/S0723202011801219.
33. Manz W, Amann R, Ludwig W, et al. Application of a suite of 16S rRNAspecific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology. 1996;142(pt 5):1097-1106.
34. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNAtargeted probes and its application in fecal samples. Appl Environ Microbiol. 1995;61:3069-3075.
35. Roller C, Wagner M, Amann R, et al. In situ probing of gram-positive bacteria with high DNA G + C content using 23S rRNA-targeted oligonucleotides. Microbiology. 1994;140(pt 10):2849-2858.
36. Sghir A, Gramet G, Suau A, et al. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol. 2000;66:2263-2266.
37. Wu GD, Lewis JD. Analysis of the human gut microbiome and association with disease. Clin Gastroenterol Hepatol. 2013;11:774-777. Available at: http://linkinghub.elsevier.com/retrieve/pii/S154235651300596X? showall=true.
38. Charlson ES, Chen J, Custers-Allen R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One. 2010;5:e15216. Available at: http://dx.doi.org/10.1371%2Fjournal.pone. 0015216.
39. Benjamin JL, Hedin CRH, Koutsoumpas A, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18:1092-1100.
40. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006;55(pt 8):1141-1149.
41. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011;60:631-637.
42. Kang S, Denman SE, Morrison M, et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis. 2010;16:2034-2042. Available at: http://dx.doi.org/10.1002/ibd.21319.
43. Manichanh C. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211.
44. Mondot S, Kang S, Furet JP, et al. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis. 2011;17: 185-192. Available at: http://dx.doi.org/10.1002/ibd.21436.
45. Noor S, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. Available at: http://www.biomedcentral.com/1471-230X/10/134.
46. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in Twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-1854.e1. Available at: http://www.sciencedirect.com/science/article/pii/S0016508510012990.
47. Moter A, Göbel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods. 2000;41: 85-112.